Results from a recent study support prior findings of the association between MS and uveitis. A diagnosis of uveitis conferred a significantly higher risk of subsequent or coincident MS and a vast ...
August 29, 2012 — The US Food and Drug Administration (FDA) has granted orphan drug status to gevokizumab (Xoma 052, Xoma Corp), a monoclonal antibody that binds strongly to interleukin 1β (IL-1β), ...
An investigational Janus kinase 1 (JAK1) preferential inhibitor reduced the risk of treatment failure among patients with active noninfectious uveitis, the phase II randomized HUMBOLDT trial showed.
An estimated five to ten percent of blindness worldwide is due to the rare inflammatory eye disease uveitis. Intermediate uveitis is often associated with a chronic course of the disease and the need ...
The inflammatory molecule interleukin-17A (IL-17A) triggers immune cells that in turn reduce IL-17A's pro-inflammatory activity, according to a new study. The inflammatory molecule interleukin-17A (IL ...
Please provide your email address to receive an email when new articles are posted on . Avoid a “kitchen sink” work-up, instead focusing on history, findings and imaging. Treatment options include ...
In a recent study published in The American Journal of Pathology, researchers provided an overview of existing research on the correlation between uveitis and gut dysbiosis. Uveitis is a rare eye ...
TxCell SA (Paris:TXCL) (FR0010127662 – TXCL), a biotechnology company developing innovative, personalized T-cell immunotherapies using antigen specific regulatory T-cells (Ag-Tregs) for severe chronic ...
Gad, O.S. and Marshood, A. (2025) Bilateral Autoimmune Multifocal Choroiditis Following COVID-19 Vaccination. Open Journal of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback